Polypharmacy and the Geriatric Patient - 09/08/11
Doi : 10.1016/j.cger.2007.01.002
Bryan D. Hayes, PharmD a, Wendy Klein-Schwartz, PharmD, MPH a, b, Fermin Barrueto, MD c, d, ⁎ 
a Maryland Poison Center, University of Maryland, School of Pharmacy, 220 Arch Street, Baltimore, MD 21201, USA
b Department of Pharmacy Practice and Science, University of Maryland, School of Pharmacy, 20 North Pine Street, Baltimore, MD 21201, USA
c University of Maryland School of Medicine, Department of Emergency Medicine, 110 South Paca Street, 6th floor-Suite 200, Baltimore, MD 21201, USA
d George Washington University, Department of Emergency Medicine, 900 23rd Street NW, Washington, DC 20037, USA
Corresponding author. University of Maryland School of Medicine, Department of Emergency Medicine, 110 South Paca Street, 6th floor-Suite 200, Baltimore, MD 21201.Abstract |
The older adult population is increasing and with it, the risk of polypharmacy. Multiple physicians treating one patient, increasing comorbidities, and an increase in the variety of drugs available contribute to the adverse effects of polypharmacy on the elderly patient. Application of Beers criteria, appropriate therapeutic drug monitoring, and careful, periodic review of the patient’s medication list will assist with preventing the sometimes lethal complications of polypharmacy.
Le texte complet de cet article est disponible en PDF.Plan
© 2007
Elsevier Inc. Tous droits réservés.
Vol 23 - N° 2
P. 371-390 - mai 2007 Retour au numéro
Article précédent
- Severe Hypertension in the Geriatric Patient—Is it an Emergency or Not?
- Robert L. Rogers, Robert S. Anderson
- Psychiatric Emergencies in the Geriatric Population
- Ben Borja, Czarina Santos Borja, Swami Gade
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?